|
|
|
|
|
|
|
|
|
|
|
25.08.26 - 17:16
|
Here′s Why Relmada Therapeutics (RLMD) Is a Great ′Buy the Bottom′ Stock Now (Zacks)
|
|
|
Relmada Therapeutics (RLMD) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term....
|
|
|
|
|
|
|
|
|
28.07.26 - 14:33
|
Relmada Therapeutics Appoints Uro-Oncology Leader Bipin Dalmia as Chief Business Officer (GlobeNewswire EN)
|
|
|
CORAL GABLES, Fla., July 28, 2026 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (Nasdaq: RLMD, “Relmada” or the “Company”), a clinical-stage biotechnology company advancing innovative therapies for oncology and central nervous system disorders, today announced the appointment of Bipin Dalmia, PhD, MBA, as Chief Business Officer. Bipin will lead Relmada's corporate strategy, commercial planning, and business development activities, reporting directly to Chief Executive Officer Sergio Traversa....
|
|
|
16.07.26 - 13:06
|
Relmada Therapeutics to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026 (GlobeNewswire EN)
|
|
|
CORAL GABLES, Fla., July 16, 2026 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (Nasdaq: RLMD, “Relmada” or the “Company”), a clinical-stage biotechnology company advancing innovative therapies for oncology and central nervous system disorders, today announced plans to host a conference call and webcast on Thursday, August 6, 2026 at 4:30 PM ET to discuss financial results for the second quarter ended June 30, 2026, and recent business progress....
|
|
|
29.06.26 - 13:03
|
Relmada Therapeutics Joins Russell 2000® and Russell 3000® Indexes (GlobeNewswire EN)
|
|
|
CORAL GABLES, Fla., June 29, 2026 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (Nasdaq: RLMD, “Relmada” or the “Company”), a clinical-stage biotechnology company advancing innovative therapies for oncology and central nervous system disorders, today announced that the Company joined the Russell 2000® Index and the Russell 3000® Index effective after the U.S. market closed on June 26, 2026, as part of the Russell Indexes reconstitution....
|
|
|
18.06.26 - 20:33
|
Relmada′s Cancer Drug Candidate Sparks Fresh Bullish Call (Benzinga)
|
|
|
HC Wainwright initiates Relmada Therapeutics (NASDAQ: RLMD) with a Buy rating and $12 target, highlighting its bladder cancer potential.
Latest Ratings for RLMD
DateFirmActionFromTo Dec 2021SVB LeerinkMaintainsOutperform Nov 2021MizuhoInitiates Coverage OnBuy Oct 2020Goldman SachsDowngradesBuyNeutral
View More Analyst Ratings for RLMD
View the Latest Analyst Ratings
Importance Rank:
1
read more...
|
|
|
11.06.26 - 13:03
|
Relmada Therapeutics Appoints CNS Drug Development Veteran Michael Quirk as Senior Advisor for Sepranolone Program (GlobeNewswire EN)
|
|
|
CORAL GABLES, Fla., June 11, 2026 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (Nasdaq: RLMD, “Relmada” or the “Company”), a clinical-stage biotechnology company advancing innovative therapies for oncology and central nervous system disorders, today announced the appointment of Michael Quirk, PhD, as Senior Advisor – Sepranolone Program. Dr. Quirk's deep expertise in CNS translational science, neuroactive steroid biology, and clinical development will be instrumental in advancing sepranolone, Relmada's GABAA receptor modulator program targeting Prader-Willi Syndrome and other CNS indications....
|
|
|
|
|
|
|
|
|
05.05.26 - 13:03
|
Relmada Therapeutics to Present NDV-01 Abstracts at AUA2026 (GlobeNewswire EN)
|
|
|
CORAL GABLES, Fla., May 05, 2026 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (Nasdaq: RLMD, “Relmada” or the “Company”), a clinical-stage biotechnology company advancing innovative therapies for oncology and central nervous system disorders, today announced the presentation of two abstracts related to NDV-01 at the American Urology Association (AUA2026), taking place from May 15-18th in Washington D.C....
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
